Parasites represent a major selective force for interleukin genes and shape the genetic predisposition to autoimmune conditions by M. Fumagalli et al.
ARTICLE
The Rockefeller University Press $30.00
J. Exp. Med. Vol. 206 No. 6 1395-1408
www.jem.org/cgi/doi/10.1084/jem.20082779
1395
It is commonly believed that infectious diseases 
have represented one of the major threats to 
human populations and have therefore acted as a 
powerful selective force. Even today, despite the 
advances in treatment and prevention, infectious 
diseases account for 48% of worldwide deaths 
among people >45 yr of age (1). These figures 
do not include the heavy burden imposed by 
helminth infections, which have recently been 
designated as the “great neglected tropical 
diseases” (2). With an estimated 2 billion indi-
viduals infected worldwide (3), helminths rep-
resent the prevalent chronic infectious diseases of 
humans. Although parasitic worms determine 
severe clinical symptoms in a minority of heavily 
infected individuals, even apparently subclinical 
parasite burdens can result in impaired nutri-
tional status and growth retardation (4, 5). It is 
therefore conceivable that several human genes 
have evolved in response to both microbial/viral 
infectious agents and parasitic worms; indeed, it 
has been suggested (6, 7) that human popula-
tions may have adapted to parasites to such a de-
gree that the lower exposure to infectious agents 
in modern developed societies results in im-
mune imbalances, with autoimmune and aller-
gic conditions being the outcome.
Genes involved in immunity and inflamma-
tion are known to be frequent targets of natural 
selection; balancing selection, which is thought 
to be a relatively rare phenomenon in humans, 
has particularly shaped the evolutionary fate of 
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Many human genes have adapted to the constant threat of exposure to infectious agents; 
according to the “hygiene hypothesis,” lack of exposure to parasites in modern settings 
results in immune imbalances, augmenting susceptibility to the development of autoim-
mune and allergic conditions. Here, by estimating the number of pathogen species/genera 
in a specific geographic location (pathogen richness) for 52 human populations and analyz-
ing 91 interleukin (IL)/IL receptor genes (IL genes), we show that helminths have been a 
major selective force on a subset of these genes. A population genetics analysis revealed 
that five IL genes, including IL7R and IL18RAP, have been a target of balancing selection, a 
selection process that maintains genetic variability within a population. Previous identifica-
tion of polymorphisms in some of these loci, and their association with autoimmune condi-
tions, prompted us to investigate the relationship between adaptation and disease. By 
searching for variants in IL genes identified in genome-wide association studies, we verified 
that six risk alleles for inflammatory bowel (IBD) or celiac disease are significantly corre-
lated with micropathogen richness. These data support the hygiene hypothesis for IBD and 
provide a large set of putative targets for susceptibility to helminth infections.
© 2009 Fumagalli et al. This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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genus. As a consequence, the prevalence of all (or at least the 
most common) pathogen species would be required. Still, 
prevalence data are difficult to combine; e.g., in endemic re-
gions, individuals can be infected with multiple parasite spe-
cies (2), and these subjects tend to harbor the most intense 
infections, possibly because of an additive and/or multiplica-
tive impact on nutrition and organ pathology (19).
To verify whether pathogen-driven selection has been act-
ing on IL genes, we exploited the fact that a set of >650,000 
single-nucleotide polymorphisms (SNPs) has been genotyped 
in 52 populations (Human Genome Diversity Project-Cen-
tre d’Etude du Polymorphisme Humain [HGDP-CEPH] 
panel: http://www.cephb.fr/en/hgdp/) distributed worldwide 
(Fig. S1) (20). Pathogen richness was evaluated by gathering 
information on the number of different pathogen species/
genera present in different geographical areas of the world 
from the Gideon database. Specifically, pathogens were di-
vided into two major groups: micro- and macropathogens. 
Micropathogens include viruses, bacteria, fungi, and protozoa. 
Macropathogens include insects, arthropods, and helminths; 
in this group parasitic worms were by far the most abundant 
class (90% of species/genera), so when we refer to macropa-
thogens we basically mean helminths. Analyses were also sepa-
rately performed for viruses, bacteria, protozoa, and fungi; 
data are available as supplemental material (Table S1). After 
data organization in Gideon, we calculated both micro- and 
macropathogen richness on a country by country basis (i.e., 
they represent the number of different micro- and macropa-
thogen species/genera per country; Fig. S1). As expected, we 
observed that micro- and macropathogen richness strongly 
correlated across geographic locations (Kendall’s rank correla-
tion coefficient = 0.67; P < 210); this is likely caused by the 
major impact of climatic factors on the spatial distribution of 
both pathogen classes (21).
IL genes were retrieved from the HGNC Gene Families/
Grouping Nomenclature web site (http://www.genenames 
.org/genefamily.html). From the resulting 99 genes, IL3RA 
and IL9R were removed because they are located on the pseu-
doautosomal regions of sexual chromosomes; IL15RB and 
IL11RB were not analyzed because their sequence and chro-
mosomal locations are not present in public databases. Finally, 
four IL9R pseudogenes were discarded. The remaining 91 
genes (Table S2) included most known ILs, their receptors, 
and receptor-accessory proteins.
A total of 1,052 SNPs in IL genes had been typed in the 
HGDP-CEPH panel, allowing analysis of all genes except for 
IL2, IL6RL1, IL6STP, IL8RBP, IL17C, IL23A, IL28A, 
IL28B, IL31, and IL34.
For all 1,052 IL gene SNPs in the dataset, we calculated 
Kendall’s rank correlation coefficient () between allele fre-
quencies in HGDP-CEPH populations and micro- or macro-
pathogen richness; a normal approximation with continuity 
correction to account for ties was used for p-value calculations. 
After Bonferroni correction for multiple tests, we observed that 
48 and 94 SNPs significantly correlate with micro- and macro-
pathogen richness, respectively, with 32 SNPs correlating with 
genes involved in immune responses (8, 9). Balancing selec-
tion is the situation whereby genetic variability is maintained 
in a population via selection. The best known example in the 
human genome affects the MHC genes, which are character-
ized by extreme polymorphism levels. Recently, Prugnolle 
et al. (10) demonstrated that populations from areas with high 
pathogen diversity display increased MHC genetic variability, 
indicating the action of pathogen-driven balancing selection.
Quite obviously, the presence of a functional variant is a 
prerequisite for selection to act, and the identification of non-
neutrally evolving genes has been regarded as a strategy com-
plementary to classical clinical and epidemiological studies to 
provide insight into the mechanisms of host defense (11). 
Similarly, analysis of the evolutionary history of genes in-
volved in immune defense might provide novel insights into 
the delicate balance between efficient response to pathogens 
and autoimmune/allergic manifestations.
In this study, we focused our attention on a large gene fam-
ily that includes ILs and their receptors (hereafter referred to as 
IL genes). ILs are small secreted molecules that regulate most 
aspects of immune and inflammatory responses and exert their 
effects through binding to specific receptors expressed on target 
cells. Various IL genes have been associated with differential 
susceptibility to specific infections (12, 13), and with an aug-
mented likelihood to develop autoimmune or allergic/atopic 
diseases (for review see reference [14]). Finally, whereas previ-
ous reports have demonstrated nonneutral evolution at single 
IL genes (15–17), no comprehensive analysis has been per-
formed and no attempt to take into account pathogen richness 
across different human populations has ever been described.
RESULTS
Pathogen-driven selection acts on IL genes
Pathogen-driven selection is a situation whereby the genetic 
diversity at a specific locus is influenced by pathogens; this is 
expected to occur because one or more alleles are associated 
with the modulation of susceptibility to infectious agents. 
One way to identify loci or variants subjected to pathogen-
driven selection is to search for correlations between genetic 
variability and pathogen richness (10, 18). The latter is a mea-
sure of pathogen diversity, and is basically calculated as the 
number of different pathogen species/genera in a specific 
geographic location (see Materials and methods for further 
details). The choice to use pathogen richness rather than more 
conventional epidemiological parameters such as prevalence/
burden stems from several considerations, as follows: (a) com-
prehensive data on prevalence are impossible to retrieve for 
many infections; (b) even when prevalence data are available, 
they may vary considerably within the same country depend-
ing on the surveyed regions, the survey period (e.g., before or 
after eradication campaigns), the population surveyed (e.g., 
city dwellers rather than farmers/bushmen/nomads or chil-
dren rather than adults); (c) the prevalence of specific infec-
tions might have changed greatly over recent years as a result 
of eradication campaigns, and historical prevalence data are 
rarely available; (d) we were not interested in a single species/
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Table I. Correlations with micro- and macropathogen richness
SNP Gene Micropathogens Macropathogens
  P-value (corrected)a Rankb  P-value (corrected)a Rankb
rs17561 IL1A 0.38 0.151 0.854 0.47 0.006 0.937
rs1143634 IL1B 0.55 <0.0001 0.996 0.58 <0.0001 0.996
rs6761276 IL1F10 0.31 2.011 0.740 0.51 0.001 0.980
rs10496447 IL1F8 0.54 <0.0001 0.995 0.57 <0.0001 0.994
rs3917304 IL1R1 0.53 <0.0001 0.994 0.51 <0.0001 0.979
rs6444444 IL1RAP 0.55 <0.0001 0.998 0.50 0.003 0.969
rs6800609 IL1RAP 0.39 0.092 0.865 0.47 0.005 0.930
rs2885373 IL1RAP 0.55 <0.0001 0.998 0.50 0.003 0.969
rs17196143 IL1RAP 0.49 0.003 0.974 0.51 0.002 0.966
rs6444435 IL1RAP 0.47 0.003 0.972 0.54 <0.0001 0.989
rs6630730 IL1RAPL1 0.41 0.079 0.883 0.53 <0.0001 0.980
rs7052954 IL1RAPL1 0.48 0.009 0.970 0.52 0.002 0.976
rs6526833 IL1RAPL1 0.43 0.020 0.923 0.52 <0.0001 0.982
rs7890572 IL1RAPL1 0.44 0.054 0.917 0.50 0.007 0.951
rs10521948 IL1RAPL1 0.49 0.003 0.974 0.54 <0.0001 0.988
rs7056388 IL1RAPL1 0.41 0.131 0.875 0.51 0.003 0.964
rs196990 IL1RAPL1 0.41 0.057 0.899 0.56 <0.0001 0.994
rs7881819 IL1RAPL1 0.38 0.406 0.830 0.51 0.003 0.966
rs10521946 IL1RAPL1 0.49 0.003 0.974 0.62 <0.0001 0.999
rs1318832 IL1RAPL1 0.51 <0.0001 0.987 0.55 <0.0001 0.995
rs5943559 IL1RAPL1 0.45 0.007 0.955 0.56 <0.0001 0.995
rs12387961 IL1RAPL1 0.37 0.261 0.832 0.46 0.009 0.928
rs721953 IL1RAPL2 0.46 0.004 0.967 0.44 0.017 0.918
rs1384360 IL1RAPL2 0.45 0.009 0.952 0.44 0.018 0.908
rs6621992 IL1RAPL2 0.45 0.010 0.955 0.46 0.008 0.940
rs7583215 IL1RL2 0.55 <0.0001 0.996 0.54 <0.0001 0.991
rs2287041 IL1RL2 0.51 <0.0001 0.985 0.47 0.004 0.945
rs3771188 IL1RL2 0.54 <0.0001 0.993 0.52 <0.0001 0.976
rs315931 IL1RN 0.41 0.040 0.916 0.46 0.007 0.941
rs2637988 IL1RN 0.44 0.011 0.953 0.47 0.004 0.954
rs2029582 IL1RN 0.30 2.565 0.728 0.46 0.008 0.936
rs3087266 IL1RN 0.34 0.728 0.780 0.46 0.008 0.928
rs2386841 IL2RA 0.48 0.002 0.970 0.47 0.004 0.942
rs11256497 IL2RA 0.49 0.002 0.973 0.49 0.002 0.953
rs2284034 IL2RB 0.37 0.244 0.834 0.48 0.003 0.950
rs1003694 IL2RB 0.32 1.570 0.734 0.46 0.006 0.936
rs228966 IL2RB 0.32 1.705 0.757 0.48 0.003 0.963
rs2284033 IL2RB 0.37 0.245 0.853 0.56 <0.0001 0.996
rs228973 IL2RB 0.44 0.012 0.943 0.52 <0.0001 0.980
rs228975 IL2RB 0.49 0.001 0.980 0.59 <0.0001 0.999
rs2235330 IL2RB 0.41 0.059 0.889 0.54 <0.0001 0.987
rs2243268 IL4 0.51 <0.0001 0.987 0.58 <0.0001 0.997
rs2243288 IL4 0.43 0.021 0.932 0.47 0.004 0.948
rs2243290 IL4 0.49 0.001 0.978 0.54 <0.0001 0.991
rs2070874 IL4 0.50 0.001 0.984 0.55 <0.0001 0.993
rs3024672 IL4R 0.40 0.189 0.866 0.53 0.001 0.975
rs3024607 IL4R 0.48 0.006 0.974 0.53 0.001 0.987
rs17026370 IL5RA 0.47 0.011 0.951 0.55 <0.0001 0.990
rs2066992 IL6 0.41 0.049 0.899 0.46 0.006 0.933
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Table I. Correlations with micro- and macropathogen richness (Continued)
SNP Gene Micropathogens Macropathogens
rs2069835 IL6 0.46 0.021 0.949 0.53 0.002 0.982
rs17505589 IL7 0.50 0.006 0.986 0.43 0.115 0.851
rs11567697 IL7R 0.43 0.086 0.904 0.51 0.005 0.972
rs1554286 IL10 0.45 0.006 0.956 0.56 <0.0001 0.994
rs3024490 IL10 0.39 0.103 0.880 0.52 <0.0001 0.988
rs2512144 IL10RA 0.38 0.343 0.832 0.47 0.009 0.938
rs999261 IL10RB 0.39 0.140 0.854 0.49 0.002 0.958
rs2243115 IL12A 0.46 0.008 0.952 0.43 0.045 0.843
rs17129789 IL12RB2 0.43 0.026 0.910 0.51 0.001 0.971
rs10521698 IL13RA2 0.40 0.164 0.860 0.50 0.003 0.956
rs1589241 IL15 0.48 0.005 0.970 0.48 0.006 0.950
rs2322262 IL15 0.47 0.008 0.962 0.49 0.005 0.953
rs13106911 IL15 0.36 0.361 0.811 0.46 0.007 0.925
rs8177636 IL15RA 0.39 0.179 0.858 0.47 0.006 0.942
rs8177685 IL15RA 0.41 0.057 0.881 0.47 0.004 0.931
rs3136614 IL15RA 0.47 0.005 0.957 0.40 0.125 0.798
rs2296139 IL15RA 0.44 0.011 0.933 0.53 <0.0001 0.985
rs12437819 IL16 0.50 0.001 0.981 0.41 0.071 0.846
rs12438640 IL16 0.50 0.001 0.982 0.41 0.060 0.854
rs10484879 IL17A 0.49 0.008 0.970 0.39 0.425 0.770
rs6518661 IL17RA 0.45 0.009 0.944 0.43 0.026 0.896
rs879576 IL17RA 0.45 0.025 0.931 0.50 0.004 0.953
rs999514 IL17RB 0.47 0.004 0.964 0.45 0.015 0.916
rs708567 IL17RC 0.40 0.066 0.890 0.51 0.001 0.976
rs6445854 IL17RD 0.43 0.030 0.912 0.52 <0.0001 0.982
rs4535195 IL17RD 0.44 0.013 0.942 0.48 0.003 0.957
rs12487790 IL17RD 0.43 0.018 0.935 0.52 <0.0001 0.983
rs17216900 IL17RD 0.45 0.009 0.946 0.36 0.368 0.779
rs12496746 IL17RD 0.46 0.006 0.951 0.42 0.048 0.866
rs455863 IL17RE 0.46 0.005 0.957 0.57 <0.0001 0.996
rs279581 IL17RE 0.39 0.116 0.878 0.50 0.001 0.974
rs279572 IL17RE 0.37 0.208 0.854 0.48 0.002 0.960
rs172155 IL17RE 0.37 0.244 0.847 0.48 0.003 0.953
rs2272128 IL18RAP 0.47 0.004 0.965 -0.39 0.125 0.829
rs2243193 IL19 0.42 0.031 0.919 0.50 0.001 0.973
rs12044804 IL19 0.48 0.002 0.973 0.62 <0.0001 1.000
rs4845143 IL19 0.41 0.042 0.910 0.49 0.001 0.969
rs12409415 IL19 0.45 0.012 0.928 0.49 0.002 0.945
rs12046559 IL19 0.43 0.021 0.923 0.54 <0.0001 0.989
rs12145973 IL19 0.59 <0.0001 1.000 0.42 0.106 0.820
rs2138992 IL19 0.46 0.006 0.959 0.52 <0.0001 0.984
rs2232360 IL20 0.38 0.166 0.858 0.46 0.007 0.934
rs1322393 IL20RA 0.39 0.098 0.876 0.49 0.002 0.963
rs1322394 IL20RA 0.38 0.206 0.844 0.48 0.003 0.948
rs75977 IL20RB -0.43 0.019 0.934 0.47 0.005 0.940
rs835634 IL20RB 0.43 0.020 0.932 0.46 0.008 0.929
rs747842 IL20RB 0.43 0.023 0.929 0.46 0.008 0.930
rs12934152 IL21R 0.57 <0.0001 0.999 0.50 0.005 0.952
rs10903022 IL22RA1 0.42 0.037 0.920 0.49 0.002 0.971
rs10751768 IL22RA1 0.42 0.030 0.926 0.50 0.001 0.974
rs3795302 IL22RA1 0.39 0.087 0.898 0.49 0.001 0.971
 o
n
 June 18, 2015
jem.rupress.org
D
ow
nloaded from
 
Published May 25, 2009
JEM VOL. 206, June 8, 2009 
ARTICLE
1399
located in clusters. This raises the possibility that many of the 
observed allele associations are spurious and derive from link-
age to a single selected allele. Yet analysis of linkage disequilib-
rium (LD; Fig. S2) indicates that linkage is not extensive across 
gene clusters, with the exception of IL17RE and IL17RC. 
Therefore, with the exception of these two genes, the remain-
ing loci are independent targets of pathogen-driven selection.
Balancing selection acts on IL1F5, IL1F7, IL1F10, IL7R,  
and IL18RAP
Pathogen-driven variations in allele frequencies can occur un-
der different selection scenarios, such as directional or balanc-
ing selection. Given the aforementioned results and the role of 
IL genes in regulating immune responses, we next verified 
whether selection signatures could be identified at IL genes by 
using classical population genetic analyses. To this aim, we 
exploited the observation that 68 out of 91 IL loci have been 
included in genetic variation projects (i.e., the SeattleSNPs 
program and the Innate Immunity in Heart, Lung and Blood 
Disease Programs for Genomic Applications) so that rese-
quencing data (although with some gaps) are available in at 
least two populations: one with European ancestry (EU) and 
one with African ancestry (either Yorubans [YRI] or African 
Americans [AA]). Common population genetics tests include 
Tajima’s D (DT) (23) and Fu and Li’s D* and F* (24). DT tests 
the departure from neutrality by comparing two nucleotide 
diversity indexes: W (25), which is an estimate of the ex-
pected per site heterozygosity, and  (26), which is the aver-
age number of pairwise sequence nucleotide differences. 
Positive values of DT indicate an excess of intermediate fre-
quency variants and are a hallmark of balancing selection; 
negative DT values indicate either purifying selection or a high 
representation of rare variants as a result of a selective sweep. 
Fu and Li’s F* and D* (24) are also based on SNP frequency 
spectra and differ from DT in that they also take into account 
whether mutations occur in external or internal branches of a 
genealogy. Population history, in addition to selective pro-
cesses, affects frequency spectra and all related statistics; for this 
reason, statistical significance was evaluated by performing co-
alescent simulations using a population genetics model that 
both. These variants map to a total of 44 IL genes (Table I). We 
next verified whether the correlations between IL SNP fre-
quencies and pathogens could be secondary to associations with 
other environmental variables (e.g., climatic factors). Hence, for 
each geographic location corresponding to HGDP-CEPH 
populations, the following parameters were obtained: average 
annual mean and maximum temperature, precipitation rate, and 
short-wave radiation flux. None of the SNPs reported in Table I 
significantly correlated with any of these variables (Table S3).
Allele frequency spectra in human populations are affected 
by selective and nonselective events; whereas selection acts on 
specific genes, nonselective forces (e.g., demography or dis-
tance from Africa [22]) are expected to affect all loci equally. 
We thus compared the strength of IL gene correlations to sets 
of control SNPs in the dataset. In particular, for each IL SNP 
in Table I, we extracted from the full HGDP-CEPH dataset all 
SNPs having an overall minor allele frequency (averaged over 
all populations) differing by <0.01 from its frequency; for all 
SNPs in the frequency-matched groups, we calculated Kend-
all’s rank correlation coefficient () between micro- and mac-
ropathogen richness and allele frequencies. We next calculated 
the percentile rank of IL gene SNPs in the distribution of 
Kendall’s  obtained for the control sets. In most cases (46 for 
micro- and 66 for macropathogens), percentile ranks higher 
than the 95th were obtained for IL SNPs. These data indicate 
that SNPs in IL genes are clearly more strongly influenced by 
pathogen richness compared with control SNPs, suggesting 
that selective forces (i.e., pathogen-driven selection), and not 
nonselective forces, are responsible for the observed associa-
tions. All data are gathered in Table I, which shows the compi-
lation of all SNPs that significantly correlate with either 
micro- or macropathogen richness; the value of  for both cor-
relations, as well as Bonferroni-corrected P values and percen-
tile ranks, are reported. It is worth noting that data in Table I 
have been organized to keep together all SNPs in the same 
gene and to group ligands and receptors; therefore, the order 
does not reflect greater association with micro- or macropatho-
gens, which can instead be inferred from correlation values.
Another issue that deserves attention relates to the ge-
nomic organization of IL genes, because many of them are 
Table I. Correlations with micro- and macropathogen richness (Continued)
SNP Gene Micropathogens Macropathogens
rs4486393 IL22RA1 0.39 0.146 0.863 0.50 0.002 0.968
rs4292900 IL22RA1 0.40 0.109 0.882 0.47 0.005 0.947
rs16829209 IL22RA1 0.39 0.156 0.856 0.50 0.002 0.959
rs11570915 IL26 0.40 0.132 0.852 0.53 0.001 0.980
rs3814240 IL26 0.42 0.026 0.929 0.49 0.002 0.964
rs3814241 IL26 0.50 0.001 0.982 0.47 0.004 0.946
rs10878789 IL26 0.47 0.004 0.962 0.41 0.052 0.868
rs9632389 IL31RA 0.48 0.005 0.960 0.43 0.058 0.837
rs10055201 IL31RA 0.39 0.120 0.869 0.45 0.009 0.927
rs1554999 IL32 0.48 0.002 0.965 0.55 <0.0001 0.988
aBonferroni-corrected p-value.
bPercentile rank relative to the distribution of SNP control sets matched for allele frequency.
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for YRI and EU in the case of IL1F7 and IL7R, respectively. 
Overall, these data suggest the action of balancing selection. 
It should be noted that IL7R is encompassed by a copy num-
ber variant (CNV; http://projects.tcag.ca/variation/); yet the 
CNV only occurs in 1 out of 110 chromosomes, and thus 
should not affect our results.
Another commonly used test to verify departure from se-
lective neutrality is the Hudson, Kreitman, and Aguade (HKA) 
test (28); it is based on the assumption that under neutral 
evolution, the amount of within-species diversity correlates 
with levels of between-species divergence because both de-
pend on the neutral mutation rate. An excess of intraspecific 
diversity compared with divergence (k > 1) is considered a 
signature of balancing selection. Here, we performed a maxi-
mum likelihood HKA test (MLHKA) (29) by comparing 
each IL gene in Table II to 16 neutrally evolving genes rese-
quenced in the same individuals (see Materials and methods 
for details). The MLHKA test rejected the neutral evolution 
model for IL1F5 and IL7R (in both populations), as well as 
IL1F10 (in YRI), but not for IL1F7 and IL18RAP. Indeed, 
in the latter case, interspecific divergence higher than the ge-
nome average paralleled the high levels of intraspecific diver-
sity (unpublished data).
Population genetic diversity, measured as FST, can also 
provide information on selective processes. Under selective 
neutrality, FST is determined by genetic drift, which is mainly 
accounted for by demographic history and similarly affects all 
genomic loci. Conversely, natural selection being a locus-spe-
cific force, it can affect FST values for specific genes. Balancing 
selection may lead to a decrease in FST compared with neu-
trally evolving loci (8); specifically, low FST values among con-
tinental populations strongly suggests the action of balancing 
selection worldwide (i.e., irrespective of local environmental 
incorporates demographic scenarios (27). Simulations were 
performed using the cosi package (27) and were used to derive 
a p-value that indicates whether or not the value obtained for 
a given IL locus is expected under a given demographic sce-
nario; a significant P value indicates that the obtained value is 
unlikely under the specified conditions and, therefore, that 
neutrality can be rejected.
Another method of figuring out the effects of selection and 
population history again lies in the assumption that selection 
acts on a single locus, whereas demography affects the whole 
genome; therefore, we calculated test statistics for 238 genes 
resequenced by the National Institute of Environmental Health 
Science (NIEHS) program (Table S4). These empirical distri-
butions were used to calculate the percentile rank of DT, D*, 
and F* values for analyzed IL genes; this procedure provides a 
direct comparison of the locus under analysis with a sample of 
human genes and allows an estimation of how unusual the 
value obtained is (e.g., a percentile rank of 0.99 suggests that 
neutral evolution is unlikely).
5 of the 68 IL genes available for population genetic anal-
ysis gave significant results in at least one population; three of 
them (IL1F10, IL7R, and IL18RAP) also display at least one 
SNP correlating with pathogen richness (Table I). Data con-
cerning W and , as well as DT, D*, and F*, are reported in 
Table II. For IL1F5, IL1F7, and IL1F10, W and  were 
close to or higher than the 95th percentile in the distribution 
of NIEHS genes in both populations, indicating an excess of 
polymorphisms at these loci; conversely, no exceptional W 
and  were observed for IL18RAP in AA and for IL7R in 
either population. Calculation of DT, D*, and F* for the five 
genes indicated that one or more statistics rejected neutral-
ity in both Africans and Europeans for IL1F5, IL1F10, and 
IL18RAP; conversely, unusually high values were obtained only 
Table II. Summary statistics for five IL genes
Gene  La  Pb  Nc Sd e f  DT  D*  F*
Value P-valueg Rankh Value P-valueg Rankh Value P-valueg Rankh
IL1F5 6.4 YRI 48 50 17.61 21.73 0.81 0.033 0.97 0.43 0.11 0.85 0.68 0.045 0.93
EU 46 39 13.87 25.33 2.84 0.0004 >0.99 1.68 0.0018 >0.99 2.49 0.0002 >0.99
IL1F7 6.1 YRI 48 45 16.57 22.07 1.14 0.016 >0.99 0.82 0.037 0.95 1.11 0.012 0.98
EU 46 35 13.02 8.69 1.13 0.10 0.15 1.18 0.046 0.96 0.43 0.28 0.69
IL1F10 4 YRI 48 34 19.36 18.98 0.066 0.21 0.76 1.15 0.012 0.98 0.85 0.027 0.95
EU 46 16 9.20 12.68 1.19 0.070 0.89 1.59 0.0041 >0.99 1.72 0.0090 0.99
IL18RAP 17.8 AA 48 97 12.30 14.24 0.56 0.039 0.95 0.69 0.013 0.94 0.77 0.011 0.96
EU 46 88 11.27 15.56 1.36 0.057 0.91 1.26 0.0099 0.97 1.54 0.013 0.98
IL7R 21 AA 48 119 12.80 9.94 0.80 0.42 0.39 0.26 0.10 0.82 0.16 0.21 0.71
EU 46 70 7.60 10.33 1.28 0.084 0.90 1.53 0.0029 >0.99 1.71 0.011 0.99
aLength of analyzed resequenced region (in kilobasepairs).
bPopulation.
cSample size (chromosomes).
dNumber of segregating sites.
ew estimation per site (×104).
f estimation per site (×104).
gP-values obtained by applying a calibrated population genetics model, as described in the text.
hPercentile rank relative to the distribution of values obtained for 238 NIEHS genes (i.e., comparison with an empirical distribution).
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neutrality for IL1F7 and IL18RAP, suggesting that relaxed 
constraint rather than balancing selection might be responsible 
for the observed high DT, D*, and F* values. Still, we noticed 
that the 6 polymorphisms within IL1F7 exons in YRI are all 
pressures), whereas reduced population differentiation within 
continents is consistent with a locally exerted selective pressure 
resulting in balancing selection. We calculated FST for the 5 IL 
genes and compared it to the distribution of this parameter 
among 238 NIEHS genes. Unusual FST values were only ob-
served for IL18RAP; in this case, a negative FST was obtained, 
indicating that the real value is close to 0, therefore corre-
sponding to a percentile rank lower than the 2.5th.
One other effect of balancing selection is the maintenance 
of divergent haplotype clades separated by deep coalescence 
times (30). We therefore studied haplotype genealogies by 
constructing median-joining networks. In particular, regions 
displaying low recombination rates were selected (see Materials 
and methods and Fig. S3); in the case of IL18RAP and IL1F10, 
network analysis was not performed because of the low LD 
throughout the gene region.
Haplotype genealogies for IL1F5, IL1F7, and IL7R re-
vealed two major clades separated by long branches (Fig. 1), 
each containing common haplotypes. To estimate the time to 
the most recent common ancestor (TMRCA) of the haplotype 
clades, we applied a phylogeny-based method (31) based on 
the measure , which is the average pairwise difference be-
tween haplotypes and a root. TMRCA estimates of 2.76 mil-
lion years (MY; SD = 660 KY), 2.10 MY (SD = 404 KY), and 
1.68 MY (SD = 408 KY) were obtained for IL1F5, IL1F7, 
and IL7R, respectively. In all cases, we verified these results 
using GENETREE, which is based on a maximum-likelihood 
coalescent analysis (32). Consistently, the resulting gene trees, 
rooted using the chimpanzee sequences, are partitioned into 
two deep branches (Fig. 2). Using this method, a second esti-
mate of the TMRCAs for the three genes was obtained (Fig. 2 
and Table S5). Estimates of coalescence times for neutrally 
evolving autosomal human loci range between 0.8 and 1.5 MY 
(33); the TMRCAs we estimated for IL1F5, IL1F7, and IL7R, 
although not exceptional, are deeper than for most neutrally 
evolving loci. Again, this finding suggests the action of balanc-
ing selection (30).
Heterozygote advantage (also known as overdominance) 
is one of the possible causes of balancing selection. To verify 
whether this is the case for the five selected IL genes, for each 
population we calculated the ratio of observed heterozygosity 
to expected gene diversity. This same ratio calculation has re-
cently been applied to human HapMap SNPs, and threshold 
values for inference of overdominance have been set to 1.160 
and 1.165 for YRI and EU, respectively (34). To obtain an ad-
ditional estimate of this parameter distribution in the human 
genome, ratios were also calculated for NIEHS genes. Whereas 
all other genes showed nonexceptional values, the observed 
heterozygosity to expected gene diversity ratio for IL1F5 
amounted to 1.07 and 1.20 for YRI and EU, respectively. This 
value is higher than the previously set threshold for EU and falls 
above the 99th percentile value obtained from NIEHS genes in 
this same population.
Overall, these data strongly suggest the action of balanc-
ing selection on these 5 IL genes reported in Tables II and III; 
it is worth mentioning that the MLHKA test failed to reject 
Figure 1. Haplotype genealogy for IL1F5, IL1F7, and IL7R gene 
regions. The analyzed regions correspond to the largest LD block for each 
gene (Fig. S2). Each node represents a different haplotype, with the size of 
the circle proportional to the haplotype frequency. Nucleotide differences 
between haplotypes are indicated on the branches of the network. Circles 
are color-coded according to population (gray, AA or YRI; white, EU). The 
chimpanzee sequence is also shown (black). Fig. S2 is available at http://
www.jem.org/cgi/content/full/jem.20082779/DC1.
 o
n
 June 18, 2015
jem.rupress.org
D
ow
nloaded from
 
Published May 25, 2009
1402 PARASITES SHAPE INTERLEUKIN GENE EVOLUTION | Fumagalli et al.
accounted for by nonsynonymous substitutions; application of 
the MK tests (35) using orangutan for divergence yielded a 
p-value of 0.058. Although not fully significant, this result indi-
cates an unusual frequency of replacement polymorphic variants 
and, together with the deeper-than-average TMRCA, is in line 
with balancing selection rather than with functional relaxation.
With respect to IL18RAP, the extremely low FST value we 
observed (Table III) is not consistent with relaxed functional 
constraints, but instead supports the idea that a balanced poly-
morphism is maintained in AA and EU, suggesting response to a 
widespread selective pressure (i.e., not local adaptation). Finally, 
it should be noted that IL1F5 and IL1F10 are located nearby, 
raising the possibility that the signatures we observe at both gene 
regions are caused by hitchhiking with a single functional variant; 
yet, LD is low across the region because of the presence of a re-
combination hotspot within the IL1F10 gene region. Moreover, 
although hitchhiking has the potential to affect large genomic re-
gions, the signatures of balancing selection are predicted to ex-
tend over relatively short distances (36, 37). We therefore consider 
that the two genes might be independent selection targets.
Risk alleles for inflammatory bowel and celiac disease 
correlate with pathogen-richness
Previous analyses showed that a polymorphism (rs917997) lo-
cated 1,500 bp downstream of IL18RAP is significantly as-
sociated with both celiac disease (CeD) and inflammatory 
bowel disease (IBD; with the SNP also influencing the level of 
gene expression (38, 39). This variant was not included in our 
analysis of pathogen correlations because of its location outside 
the gene region (as defined in Materials and methods). Still, 
we observed that rs917997 is in strong LD (D’ = 1 and 0.87 in 
EU and YRI, respectively) with rs2272128, which we found 
to correlate with macro- and micropathogen richness. We 
therefore checked the presence of rs917997 and verified that 
the risk allele for CeD and IBD also correlates significantly 
with pathogen richness (Table IV). Stimulated by this finding, 
we next verified whether the frequency distribution of other 
Figure 2. Estimated trees for IL1F5, IL1F7, and IL7R gene regions. 
The analyzed regions correspond to the largest LD block for each gene 
(Fig. S2). Mutations are represented as black dots and named for their 
physical position along the regions. The absolute frequency of each  
haplotype is also reported. Fig. S2 is available at http://www.jem 
.org/cgi/content/full/jem.20082779/DC1.
Table III. MLHKA test and FST for five IL genes
Gene Pa MLHKA FST (rankb)
kc P-value
IL1F5 YRI 2.92 0.0043 0.13 (0.53)
EU 2.85 0.0032
IL1F7 YRI 1.82 0.29 0.28 (0.89)
EU 1.91 0.29
IL1F10 YRI 2.38 0.017 0.16 (0.62)
EU 1.46 0.56
IL18RAP AA 1.18 0.22 0 (<0.025)
EU 1.62 0.38
IL7R AA 2.53 0.0042 0.019 (0.084)
EU 2.14 0.028
aPopulation.
bPercentile rank relative to the distribution of FST values calculated for 238 NIEHS 
genes.
cSelection parameter.
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review see reference [40]). These parasites evolve at lower rates 
than viruses and bacteria and, in contrast to most viral/micro-
bial agents, are able to maintain themselves in small human 
communities (41). Notably, by establishing chronic infections, 
parasitic worms affect the susceptibility of their host to viruses, 
bacteria, and protozoa (for review see reference [2]). There-
fore, helminths might have represented a stable threat to human 
populations and their distribution, which is not associated with 
sudden epidemics and, as in the case of micropathogens, might 
have left stronger genetic signatures.
A limitation of our study is that we implicitly assumed that 
the number of different pathogen species/genera per country 
has been maintained proportionally unchanged along human 
evolutionary history. Although clearly an oversimplification, 
this might reflect reality to some degree, given that climatic 
variables (e.g., precipitation rates and temperature) have a pri-
mary importance in driving the spatial distribution of human 
micro- and macropathogens (21). Therefore, while the fitness 
cost imposed by specific species/genera might have evolved 
rapidly, the relative number of pathogen species per country 
might have changed proportionally less.
Another possible caveat of our results concerns the defini-
tion of “pathogen,” in that we included any organism that can 
cause a disease irrespective of its virulence or pathogenicity. 
The reason for this choice is that the fitness of a pathogen is a 
direct measure of the ability of such pathogen to replicate 
within a given environment. Fitness is dependent on both the 
features of the pathogen and of the host. The features of the 
susceptibility alleles in IL genes has been influenced by patho-
gen richness. To analyze only variants that have been identi-
fied in an unbiased manner (i.e., without a priori hypothesis 
on the genes involved), we searched among published genome-
wide association studies for SNPs in IL genes that have been 
associated with any trait. For available variants in the CEPH-
HGDP panel, we next calculated correlations with micro- and 
macropathogen richness. Results reported in Table IV indi-
cate that six out of nine risk variants for CeD or IDB/Crohn’s 
disease (CD) were associated with micro- and macropathogen 
richness; in particular, two of them located within IL23R are 
in tight LD, and thus do not represent independent observa-
tions. Noticeably, in all six cases, the risk allele correlates with 
pathogen richness and correlations with micropathogens were 
stronger compared with macropathogens (with the exception 
of rs11465804), a situation different from the general observa-
tion that macropathogens have represented a more powerful 
selective pressure on IL genes.
DISCUSSION
We analyzed the recent evolutionary history of IL genes in 
humans by integrating information on environmental variables 
with classical population genetics and association studies. Re-
sults herein suggest that microbes and parasitic worms played a 
relevant role as selective agents, but the pressure imposed by 
helminths on IL genes has been stronger than the one caused 
by viral and microbial agents. Helminths were present among 
our ancestors before the emergence of humans as a species (for 
Table IV. Correlations with micro- and macropathogen richness for SNPs associated with different traits
SNP Gene/location Allele Micropathogen Macropathogen Trait/disease
Risk Anc.a b P-valuec b P-valuec
rs6897932 IL7R C C 0.22 n.s.d 0.21 n.s.d Multiple sclerosis/Type 1 diabetes
rs917997 IL18RAP 
(downstream)
A G 0.42 <0.001 0.35 0.008 CeD/IBD
rs10045431 IL12B C C 0.43 <0.001 0.34 0.015 CD
rs7517847 IL23R C A 0.23 n.s.d 0.26 n.s.d IBD
rs11209026 IL23R G G 0.47 <0.001 0.44 0.001 IBD
rs11465804 IL23R T T 0.39 0.004 0.44 <0.001 CD
rs6822844 IL2/IL21 (intergenic) G G 0.40 0.004 0.39 0.006 CeD
rs3024505 IL10 T C 0.28 n.s.d 0.28 n.s.d Ulcerative colitis
rs17810546 IL12A G A 0.03 n.s.d 0.11 n.s.d CeD
rs13015714 IL18R1 C A 0.47 <0.001 0.39 0.002 CeD
rs2250417 IL18 A A 0.23 n.s.d 0.26 n.s.d Protein quantitative trait loci
rs7626795 IL1RAP G A 0.20 n.s.d 0.04 n.s.d Lung cancer
rs4129267 IL6R C C 0.17 n.s.d 0.24 n.s.d Protein quantitative trait loci/pulmonary 
function
rs6761276 IL1F10e n.r.f T 0.31 0.030 0.51 <0.001 Protein quantitative trait loci
rs12251307 IL2RA T T 0.16 n.s.d 0.13 n.s.d Type 1 diabetes
aAncestral state based on chimpanzee sequence.
bThe correlation coefficient is calculated between pathogen richness and the risk allele frequency;.
cBonferroni-corrected p-value (15 tests).
dNonsignificant (P > 0.05).
eThis SNP is located within IL1F10, but affects IL1RN protein levels.
fNot reported.
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plex that binds IL-15 (50). IL-15 has a central role in intesti-
nal inflammatory processes and in the pathogenesis of CD 
and CeD (51), possibly participating in the immune protec-
tion of gut tissues. An interesting observation is that IL-2RB, 
via IL-15 binding, regulates the intestinal epithelial barrier by 
transducing signals that result in tight junction formation 
(52). Variation of mucosal permeability after nematode infec-
tion is a host defense response and is important for efficient 
parasite expulsion (53); the correlation we observed between 
SNPs in these genes and macropathogen richness might indi-
cate selection for improved intestinal clearance of nematodes. 
Again, mouse models will prove central in addressing the role 
of these loci in parasite expulsion; e.g., in the case of IL4R, 
which also correlates with helminth richness (Table I), treat-
ment with antibodies or use of il4r-deficient mice prevented 
expulsion of Heligmosomoides polygyrus, Trichuris muris, and 
Nippostrongylus brasiliensis (54).
A major locus for susceptibility to Schistosoma mansoni in-
fection (SM1) has previously been mapped to 5q31-q33 (55). 
This region covers IL4, IL5, IL3, IL13, IL9, and IL12B, as 
well as other candidate loci (IRF1 and CSF2). Although our 
data do not allow inference on which gene is responsible for 
increased susceptibility to schistosomiasis, it is worth noting 
that four SNPs in IL4 display very strong correlation with hel-
minth richness. IL4 might therefore be regarded as a candidate 
locus for susceptibility to S. mansoni infection, with dedicated 
association studies being required to verify this prediction. 
Conversely, the SM2 region (6q22-q23), where a locus con-
trolling hepatic fibrosis in S. mansoni infection has been mapped 
(56), harbors no IL genes.
Pathogen-driven variations in allele frequencies can occur 
under different selection scenarios, such as directional or bal-
ancing selection; the latter itself is the result of an initial stage 
of positive selection that favors the spread in a population of a 
new allele until selection opposes its fixation and a balanced 
situation is established. Common causes of balancing selection 
include heterozygote advantage, changing environmental con-
ditions, and frequency-dependent selection, all of these possi-
bly applying to host–pathogen interactions. Also, given the 
pleiotropic roles of many IL genes, selective pressures different 
from pathogen richness might affect the evolutionary fate of 
these loci. Classical population genetics analyses indicated that 
five IL genes are likely targets of balancing selection. IL1F5, 
IL1F7, and IL1F10 are recently discovered IL-1 family mem-
bers (57) that are located within the IL1 gene cluster; based on 
comparative analyses, IL-1F5 and IL-1F10 are predicted to act 
as antagonists (58). IL1F5 is a regulator of skin and brain in-
flammation (59, 60) and it is expressed in many different human 
tissues (57). Interestingly, an excess of heterozygotes was ob-
served for IL1F5, suggesting that overdominance might un-
derly the maintenance of a balanced polymorphism in the 
gene. Overdominance is rare in humans (36, 61) and is hy-
pothesized to enhance immune response flexibility by modu-
lating allele-specific gene expression in different cell types and 
in response to diverse stimuli/cytokines (62). Whether this is 
the case for IL1F5 remains to be verified.
pathogen include its abilities to (a) replicate within the host, 
(b) select a proper cell target (tropism), (c) avoid the immune 
response, and (d) escape the obstacles posed by drugs. The fea-
tures of the host include the immune response, the genetic 
background, and the availability of target cells. The reciprocal 
balance between these factors determines the virulence of a 
pathogen, a feature that, therefore, cannot be considered as a 
constant, but rather evolves dynamically over time.
Despite these limitations, we were able to identify several 
variants that are likely candidates for pathogen-driven selec-
tion, and the suitability of this approach is confirmed by the 
previous demonstration that variability at HLA genes correlates 
with a similar measure of pathogen richness (10). Our data 
point to the SNPs in Table I as good candidates for experi-
mental analyses aimed at inferring their role in IL gene func-
tion, given that a signature of natural selection necessarily 
implies the presence of a functional variant (either the corre-
lated variant itself or a linked one). Also, genes subjected to a 
selective pressure from infectious diseases should be regarded 
(42) as obvious candidates for genetic epidemiology studies (e.g., 
case-control studies).
It is worth noting that most members of the IL-1 signal-
ing pathway were observed to correlate with pathogen rich-
ness. IL-1A and IL-1B are pleiotropic cytokines with central 
roles in immune and inflammatory responses (43) required 
for the development of Th2-mediated immunity and protec-
tion against chronic infection in mice (44). The observation that 
SNPs strongly correlated with micro- and macro-pathogen 
richness map to IL1RAPL1 is more puzzling, as this gene is 
not known to be associated with infection and immune re-
sponse, but is involved in brain development and function 
(45); nonetheless, this gene is expressed in tissues that are dif-
ferent from brain (46), suggesting that it plays other roles 
apart from neurodevelopment.
Strong correlations with macropathogen richness were ob-
tained for IL4, IL4R, and IL10. These molecules are pivotal to 
the elicitation of Th2 response, which is the immune response 
central to helminth resistance (40, 47). The strongest correla-
tion with macropathogens was observed for rs12044804 in 
IL19 ( = 0.62). This gene is located within an IL cluster, 
which also comprises IL10 and IL20, and is encompassed by a 
low-frequency CNV. The low levels of LD across the IL clus-
ter (Fig. S2) suggest that IL19, IL20, and IL10 SNPs are inde-
pendently associated with pathogen richness. IL19, IL20, IL22, 
IL24, and IL26 all belong to the IL-20 subfamily, are all pro-
duced by different leukocyte populations, and all bind to par-
tially shared receptors that are mainly expressed by epithelial cells 
and known to promote keratinocyte growth and to induce skin 
inflammatory responses (48, 49). The correlation of SNPs in 
most of these genes with micropathogen and helminth rich-
ness suggests that modulation of skin immunological properties 
might represent an adaptive response to parasite species that 
infect humans through the skin.
SNPs in IL2RB, IL15, and IL15RA also correlated with 
macropathogen richness; these genes converge on the same 
pathway as IL-2RB and IL-15RA are part of a trimeric com-
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confer stronger protection against viruses/bacteria and there-
fore likely elicit more vigorous Th1 responses. Living condi-
tions in industrialized countries have resulted in a reduction of 
both helminth and bacterial/viral infection. The effect of this 
environmental change on the homeostasis of immune responses 
might be difficult to reconcile with simple theories (71). In 
this complex scenario, we consider that evolutionary studies 
and population genetics approaches, such as the one proposed 
here, provide some insight into the genetic basis of predisposi-
tion to infectious and autoimmune diseases.
MATERIALS AND METHODS
Data retrieval and haplotype construction. Data concerning the HGDP-
CEPH panel derive from a previous work (20). A SNP was ascribed to a spe-
cific gene if it was located within the transcribed region or no further than 
500 bp upstream the transcription start site.
Genotype data for resequenced IL genes were retrieved from the Seattle-
SNPs (http://pga.mbt.washington.edu) and Innate Immunity PGA (http://
innateimmunity.net/) web sites. A total of 68 genes were available for analy-
sis. For each gene, genotypes deriving from 24 subjects of African ancestry 
and 23 of Caucasian ancestry were retrieved.
Genotype data for 238 resequenced human genes were derived from the 
NIEHS SNPs Program web site (http://egp.gs.washington.edu). We specifi-
cally selected genes that had been resequenced in populations of defined eth-
nicity (NIEHS panel 2).
Haplotypes were inferred using PHASE version 2.1 (72), a program for 
reconstructing haplotypes from unrelated genotype data through a Bayesian 
statistical method.
Recombination rates were derived from the University of California at 
Santa Cruz genome browser web site (http://genome.ucsc.edu). Information 
concerning CNVs was derived from the database of genomic variants (http://
projects.tcag.ca/variation/).
Variants and risk alleles identified in genome-wide association studies 
were retrieved from the National Human Genome Research Institute web site 
(http://www.genome.gov/) updated on December 1, 2008.
Statistical analysis. DT (23), Fu and Li’s D* and F* (24) statistics, and diversity 
parameters W (25) and  (26) were calculated using libsequence (73). Coales-
cent simulations were performed using the cosi package (27) and its best-fit pa-
rameters for YRI, AA, and EU populations with 104 iterations. cosi is a simulation 
package based on a population genetics model calibrated on empirical data; it 
therefore allows incorporation of demographic scenarios in simulations.
The FST statistic (74) estimates genetic differentiation among popula-
tions and was calculated as previously proposed (75).
The maximum likelihood ratio HKA test was performed using the ML-
HKA software (29) as previously described (18). In brief, we used multilocus 
data of 16 selected genes and Pan troglodytes (NCBI panTro2) as an outgroup 
(except for IL1F7, where Pongo pygmaeus abelii, NCBI ponAbe2, was used as 
the outgroup). The 16 reference genes were randomly selected among 
NIEHS loci <20 kb that have been resequenced across panel 2; the only cri-
terion was that no reference gene rejected the neutral model (i.e., that no 
gene yielded significant DT). The reference loci used were as follows: VNN3, 
PLA2G2D, MB, MAD2L2, HRAS, CYP17A1, ATOX1, BNIP3, CDC20, 
NGB, TUBA1, MT3, NUDT1, PRDX5, RETN, and JUND.
LD analyses were performed using Haploview (76), and haplotype 
blocks were identified through an implemented method.
Median-joining networks to infer haplotype genealogy were con-
structed using NETWORK 4.5 (31). Estimate of the TMRCA was obtained 
using a phylogeny-based approach implemented in NETWORK using a 
mutation rate based on the number of fixed differences between human and 
chimpanzee or orangutan and assuming a separation time from humans of 
6 MY and 13 MY ago, respectively. A second TMRCA estimate was derived 
from application of a maximum-likelihood coalescent method implemented 
IL1F10 is a still relatively unknown protein mainly ex-
pressed in skin, proliferating B cells, and tonsils (63). One of 
the intermediate frequency SNPs in the gene is accounted for 
by a missense substitution that replaces an aspartic acid resi-
due with an alanine (Asp51Ala); the presence of a negatively 
charged residue at this position is conserved among mammals 
(Fig. S4), possibly suggesting functional significance and await-
ing experimental testing.
In analogy to IL1F5, the other IL1 family member we 
identified as rejecting neutral evolution, i.e., IL1F7, also acts as 
an antiinflammatory molecule (64).
IL1F5, IL1F7, and IL1F10 are not known to be involved 
in human diseases; in contrast, IL18RAP and IL7R play a role 
in triggering immune responses. The IL-7/IL-7R ligand-re-
ceptor pair is central to the proliferation and survival of B and T 
leukocytes. We identified one SNP in the gene as highly 
correlated with macropathogen richness (Table I). This is not 
surprising given the role of Th2 responses in helminth infec-
tion and the involvement of IL-7R in the TSLP signaling 
pathway (65), which in turn regulates Th2-mediated inflam-
matory responses (66).
Similar to IL7R, IL18RAP plays a known role in human pa-
thology. The gene encodes a component of the protein complex 
involved in transducing IL-18 signal, resulting in the activation 
of NF-B (67). The IL-18 receptor complex is expressed in the 
intestine (38), and one SNP immediately downstream IL18RAP 
(rs917997) has been associated with both CeD and IBD (38, 39). 
We found the predisposing allele of rs917997 and a linked vari-
ant (rs2272128) to correlate with pathogen richness. The loca-
tion of rs2272128 in the 5 gene region and its strong correlation 
with pathogens might suggest that it (rather than rs917997) rep-
resents or is in close LD with the functional allele. Moreover, the 
correlation of a risk allele for autoimmune diseases with patho-
gen-richness suggests an interesting link between adaptation and 
disease. Indeed, we observed that five more risk alleles for either 
IBD or CeD significantly correlate with micro- and macropa-
thogen richness. Albeit preliminary, these data suggest that infec-
tious agents have shaped the genetic variation at IL loci involved 
in intestinal inflammatory processes and, as a consequence, the 
genetic predisposition to both CeD and CD/IBD.
A north–south gradient for IBD prevalence has been de-
scribed in both the US and Europe (68). This observation, to-
gether with the increase of IBD prevalence in the last 40 yr 
(68) and the hypothesis that helminths elicit Th2-mediated 
responses, led to the proposal that lower exposure to parasitic 
worms in the setting of industrialized countries results in un-
balanced immune response, and eventually predisposes to IBD 
(68, 69). The so-called hygiene hypothesis, which clearly im-
plies evolutionary considerations concerning human–patho-
gen interactions, has been supported by recent studies in both 
humans and mice (40, 68–70). Data herein seem to indicate 
that a portion of CeD- and IBD-predisposing alleles have 
been selected by micropathogen richness, pointing to an adap-
tive role for these variants. Although not directly supportive of 
the “IBD hygiene hypothesis,” these results indicate a higher 
disease predisposition in subjects carrying IL SNP variants that 
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in GENETREE (32). Again, the mutation rate  was obtained on the basis 
of the divergence between human and a primate, assuming a generation time 
of 25 yr. Using this  and the maximum likelihood  (ML), we estimated 
the effective population size parameter (Ne). With these assumptions, the 
coalescence time, scaled in 2Ne units, was converted into years. For the co-
alescence process, 106 simulations were performed. All calculations were 
performed in the R environment (www.r-project.org).
Environmental variables. Pathogen absence/presence matrices for the 21 
countries where HGDP-CEPH populations are located were derived from 
the Gideon database (http://www.gideononline.com) following previous 
methods (10, 18). Information in Gideon is updated weekly and derives 
from WHO reports, National Health Ministries, PubMed searches, and epi-
demiology meetings. The Gideon Epidemiology module follows the status 
of known infectious diseases globally, as well as in individual countries, with 
specific notes indicating the disease’s history, incidence, and distribution per 
country. We manually curated pathogen absence/presence matrices by ex-
tracting information from single Gideon entries. These may refer to either 
species or genera (in case data are not available for different species of a same 
genus). Following previous suggestions (10, 18), we recorded only species/
genera that are transmitted in the 21 countries, meaning that cases of trans-
mission caused by tourism and immigration were not taken into account; 
also, species that have recently been eradicated as a result, for example, of 
vaccination campaigns, were recorded as present in the matrix. A total of 283 
pathogen species were retrieved (Table S6). Other environmental variables 
such as average annual mean and maximum temperature, precipitation rate, 
and short-wave radiation flux were derived for the geographic coordinates 
corresponding to HGDP-CEPH populations from the NCEP/NCAR data-
base (http://www.cdc.noaa.gov/PublicData/).
Online supplemental material. Table S1 shows correlations between the 
richness of viruses, bacteria, protozoa, and fungi. Table S2 is a list of IL genes 
analyzed in the study. Table S3 shows correlations with climatic variables. 
Table S4 provides diversity indexes and summary statistics for 238 human 
genes resequenced by the NIEHS program. Table S5 shows GENETREE 
estimates for IL1F5, IL1F7, and IL7R. Table S6 is a list of pathogen species/
genera identified in at least one population. Fig. S1 shows the geographic lo-
cation and pathogen richness estimates for the 52 HGDP-CEPH popula-
tions. Fig. S2 shows LD structure for IL gene clusters. Fig. S3 reports LD 
blocks for IL1F5, IL1F7, and IL7R. Fig. S4 shows multiple protein align-
ment for IL-1F10. Online supplemental material is available at http://www 
.jem.org/cgi/content/full/jem.20082779/DC1.
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